What is the appropriate evaluation for a 62-year-old woman presenting with giant platelets, thrombocytopenia, unexplained weight loss, and carotid and subclavian bruits?

Evaluation for Suspected Myelodysplastic Syndrome with Large Vessel Vasculitis

This patient requires immediate bone marrow evaluation with aspirate, biopsy, and cytogenetic analysis to diagnose myelodysplastic syndrome (MDS), combined with vascular imaging to evaluate for large vessel vasculitis—specifically giant cell arteritis or Takayasu arteritis—as the combination of giant platelets with thrombocytopenia, weight loss, and carotid/subclavian bruits strongly suggests a dual diagnosis of MDS with concurrent vasculitis.

Primary Hematologic Workup

The presence of giant platelets with thrombocytopenia is a hallmark of megakaryocytic dysplasia, which is specifically listed as a peripheral blood finding in MDS 1, 2. The European LeukemiaNet guidelines mandate the following diagnostic approach:

Mandatory Initial Tests

• Peripheral blood smear evaluation by a qualified hematologist/pathologist to assess dysplasia in all cell lines and enumerate blasts 1, 2
• Bone marrow aspirate examining at least 500 cells, including 100 erythroblasts and 30 megakaryocytes, to evaluate dysplasia and enumerate blasts 1
• Bone marrow biopsy to assess cellularity, fibrosis, and megakaryocytic dysplasia (which is better evaluated on sections than smears) 1, 2
• Cytogenetic analysis of bone marrow cells (20-25 metaphases) to detect clonal chromosomal abnormalities that provide both diagnostic and prognostic information 1

Recommended Additional Tests

• Flow cytometry immunophenotyping to detect abnormalities in hematopoietic compartments 1, 2
• Iron staining (Prussian blue/Perls stain) to evaluate for ring sideroblasts 2

The 62-year-old age is particularly relevant, as bone marrow examination is specifically recommended in patients older than 60 years with systemic symptoms 3.

Critical Differential Consideration

Important caveat: While MDS is the primary concern, inherited thrombocytopenias with giant platelets must be excluded, particularly MYH9-related disorders (May-Hegglin anomaly, Fechtner syndrome, Sebastian syndrome) 4. These conditions can present with:

• Giant platelets and thrombocytopenia (20,000-120,000/μL)
• Mean platelet volume 15-20 fL
• Leukocyte inclusion bodies visible on peripheral smear 4

However, the presence of weight loss and vascular bruits makes acquired MDS far more likely than hereditary conditions.

Vascular Evaluation

The combination of carotid and subclavian bruits with constitutional symptoms (weight loss) in a 62-year-old woman raises concern for large vessel vasculitis:

Required Vascular Studies

• Inflammatory markers: ESR and CRP (typically markedly elevated in giant cell arteritis)
• Vascular imaging: CT angiography or MR angiography of the aorta and its branches to evaluate for:
  • Arterial wall thickening
  • Stenosis or occlusion of subclavian/carotid arteries
  • Aortic involvement

Temporal Artery Considerations

• Physical examination of temporal arteries for tenderness, decreased pulsation, or nodularity
• Temporal artery biopsy if giant cell arteritis is suspected (though subclavian involvement suggests large vessel variant)

Algorithmic Approach

Step 1: Obtain complete blood count with manual differential and peripheral smear review

• Confirm thrombocytopenia and giant platelets
• Assess for dysplasia in other lineages
• Look for leukocyte inclusion bodies (to exclude hereditary syndromes)

Step 2: If dysplasia confirmed, proceed immediately to bone marrow evaluation

• Aspirate with morphologic assessment
• Biopsy for cellularity and fibrosis
• Cytogenetics (mandatory)
• Flow cytometry (recommended)

Step 3: Simultaneously obtain inflammatory markers and vascular imaging

• ESR, CRP
• CT or MR angiography of great vessels

Step 4: Based on results:

• If MDS confirmed with elevated inflammatory markers and vascular abnormalities → treat both conditions
• If MDS confirmed without vasculitis → standard MDS management per risk stratification
• If vasculitis without MDS → reconsider diagnosis and evaluate for other causes of thrombocytopenia

Critical Pitfalls to Avoid

1. Do not assume immune thrombocytopenia (ITP) in a 62-year-old with giant platelets and systemic symptoms—bone marrow evaluation is essential 3, 5

2. Do not delay bone marrow biopsy waiting for other test results—the combination of findings warrants immediate evaluation 1, 2

3. Do not miss concurrent vasculitis—the vascular bruits with weight loss are not explained by MDS alone and require separate evaluation

4. Do not confuse with hereditary thrombocytopenia—while MYH9-related disorders can present similarly, the age of presentation and constitutional symptoms favor acquired disease 4

The mortality and morbidity implications are significant: untreated MDS can progress to acute leukemia, while untreated large vessel vasculitis can cause stroke, aortic aneurysm, or blindness. Quality of life is severely impacted by both conditions, making rapid, comprehensive diagnosis essential.